Incruse Ellipta and Tacrolimus Capsules
Determining the interaction of Incruse Ellipta and Tacrolimus Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Tacrolimus Extended-Release Capsules
- Incruse Ellipta-Tacrolimus Extended-Release Tablets
- Incruse Ellipta-Tacrolimus Granules for Suspension
- Incruse Ellipta-Tacrolimus Injection
- Incruse Ellipta-Tacrolimus Intravenous
- Incruse Ellipta-Tacrolimus oral and injection
- Tacrolimus Capsules-Indacaterol
- Tacrolimus Capsules-Indacaterol and Glycopyrrolate
- Tacrolimus Capsules-Indacaterol and glycopyrrolate Inhalation
- Tacrolimus Capsules-Indacaterol inhalation
- Tacrolimus Capsules-Indacaterol Maleate
- Tacrolimus Capsules-Indapamide